Hamid Baniasadi, Ph.D., is an Assistant Professor in the Department of Biochemistry at the University of Texas Southwestern Medical Center, as well as the Director of Metabolomics Core Facility within the Biochemistry Department.

Dr. Baniasadi holds a bachelor's degree in chemistry from Kerman University, Iran. He earned a master's degree in chemistry from the Ball State University, Muncie, IN. Hamid received his Ph.D. degree in analytical chemistry from Purdue University, West Lafayette IN, and completed his postdoctoral training at the University of Minnesota, Minneapolis, MN.

His Ph.D. research focused on the development and application of mass spectrometry based metabolomics for the discovery of disease biomarkers. Dr. Baniasadi has extensive experience over the past 14+ years with MS based metabolomics studies, including targeted and untargeted (global) metabolite analysis using various types of mass spectrometers including: GC-MS, LC-MS (linear ion trap), LC-MS/MS (triple quadrupole) and LC-TOF-MS. He joined the faculty of the University of Texas Southwestern Medical Center in 2017.


  • Doctorate of Philosophy in Analytical Chemistry, Purdue University, West Lafayette, IN (2013)
  • Master of Science in Chemistry, Ball State University, Muncie, IN (2008)
  • Master of Science in Chemistry, Birjand University, Iran (2000)
  • Bachelor of Science, Kerman University, Iran (1994)
  • Postdoctoral Associate at the Masonic Cancer Center, University of Minnesota, Minneapolis, MN (2013-2015)

US Patent

D. Raftery, J. Bowers, Siwie, H.R. Baniasadi, Metabolite biomarkers for the detection of liver cancer, D. Raftery, J. Bowers, Siwie, H.R. Baniasadi. Date filed; May 21, 2013

Research Interest

  • Biomarker discovery based on metabolomics research
  • Cancer and Metabolism
  • LC-MS and LC-MS/MS Methods development
  • Targeted and untargeted metabolomics


Featured Publications LegendFeatured Publications

Interactions between Enterohemorrhagic Escherichia coli (EHEC) and Gut Commensals at the Interface of Human Colonoids
Fernando H. Martins, Anubama Rajanc, Hannah E. Carterc, Hamid R. Baniasadi, Anthony W. Maresso, Vanessa Sperandio mBio 2022 Jun 28;13(3):e0132122
TMEM120A is a coenzyme A-binding membrane protein with structural similarities to ELOVL fatty acid elongase
Xue J, Han Y, Baniasadi H, Zeng W, Pei J, Grishin NV, Wang J, Tu BP, Jiang Y Elife 2021 Aug 10: e71220
Assessing the Safety of Transarterial Locoregional Delivery of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles to the Rat Liver
Junjie Li, Diana Canseco, Yuzhu Wang, Goncalo Dias do Vale, Jaideep Chaudhary, Arnida Anwar, Hamid Baniasadi, Benjamin Tu, Noelle Williams, Purva Gopal, Patrick Sutphin, Jeffrey G. McDonald, William C. Putnam and Ian R. Corbin Eur J Pharm Biopharm 2021 Jan;158:273-283
The Lon protease links nucleotide metabolism with proteotoxic stress
Rilee D. Zeinert, Hamid Baniasadi, Benjamin Tu, Peter Chien Mol Cell 2020 Sep 3;79(5):758-767
Metabolite biomarkers for the detection of liver cancer
D. Raftery, J. Bowers, Siwie, H.R. Baniasadi US Patents, Publication number: US20150133331 A1 2015 May 14
Statistical Analysis and Modeling of Mass Spectrometry-Based Metabolomics Data
B. Xi, H. Gu, H. R. Baniasadi, Daniel Raftery Chapter 22, Mass Spectrometry in Metabolomics, Methods in Molecular Biology 2014 1198 pp 333-353
The Effect of Genetics and Environment on the Metabolome of Commercial Maize Hybrids Using LC/MS: A Multisite Study
H. R. Baniasadi, C. Vlahakis, J. Hazebroek, C. Zhong, V. Asiago Journal of Agricultural and Food Chemistry 2014 62 (6), 1412-1422
Targeted Metabolic Profiling of Hepatocellular Carcinoma and Hepatitis C using LC-MS/MS
H. R. Baniasadi, G. A. Nagana Gowda, A. Zeng, S. Zhuang, M. Maluccio, D. Raftery Electrophoresis 2013 1-8
Targeted serum metabolite profiling of nucleosides in esophageal adenocarcinoma
Djukovic, H. R. Baniasadi, R. K, Z. Hammoud, D. Raftery Rapid Communications in Mass Spectrometry 2010 24, 3057-3062

Professional Associations/Affiliations

  • American Chemical Society (2007)
  • American Society for Mass Spectrometry (2012)
  • Metabolomics Society (2020)